Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Fifth Circuit Strikes Down CTA Injunction, FinCEN Extends Deadline to Jan. 13, 2025

Bulls, Bears, and Blockchain™ – December 26, 2024

Blockchain Monitor

Weekly Blockchain Blog – December 23, 2024

What to Expect and How to Prepare: A Guide to Employing Foreign Workers in the Age of Trump

Tim’s years as a process chemist in the pharmaceutical and chemical industries and as a Hatch-Waxman litigator give him invaluable experience and insight into the complexities surrounding all forms of chemistry-related intellectual property. As a result, he is able to thoroughly analyze complex issues and develop efficient solutions to the problems confronting&nbsp;clients.

core/freeform

J.D., Seton Hall University School of Law, 2010, 

Ph.D., Organic Chemistry, Georgia Institute of Technology, 1996

B.S., Chemistry, West Virginia University, 1989

<ul>
<li><em>The Best Lawyers in America®</em>
<ul>
<li>&#8220;Ones to Watch&#8221; in Pennsylvania for Intellectual Property Law (2024 to 2025)</li>
</ul>
</li>
</ul>


Philadelphia

The Legal Intelligencer Congratulates New Philadelphia Office Partners

BakerHostetler Elevates 23 Attorneys to Firm Partnership

Intellectual Property

IP Life Sciences and Advanced Materials

Patent Prosecution

<h5>Patent Prosecution</h5>
<ul>
<li>Drafted and prosecuted U.S. and Patent Cooperation Treaty patent applications in pharmaceutical and chemical arts.</li>
<li>Developed small molecule patent portfolios for several start-up pharmaceutical companies, which enabled the companies to generate investment capital including by initial public offering.</li>
</ul>
<h5>Patent Opinions</h5>
<ul>
<li>Drafted freedom-to-operate and validity opinions relating to APIs, polymorphs, pharmaceutical dosage forms, methods of use, and API and dosage form manufacturing processes, which allowed clients to guide future research and development efforts.</li>
</ul>
<h5>Patent Litigation</h5>
<ul>
<li>Experienced in all aspects of patent litigation (including Hatch-Waxman litigation), including pleadings, fact and expert discovery, Markman hearings, motion practice, trials and appeals.</li>
</ul>


Timothy J. Doyle, Ph.D.

Timothy J. Doyle, Ph.D.

Experience

Recognitions and Memberships

Insights and News

Prior Positions

Credentials

Community and Pro Bono

Areas of Focus

Services

Featured Insights